Promoted as being safer than systemic antibiotics, a 3% formulation of topical minocycline gel has passed Phase 2 clinical trials and is readying to commence Phase 3 trials. The owners of the product, currently named HY-01 – Hovione are promoting their in-development topical as more moisturising than other comparable topicals, and less likely to induce […]

More...